PedAM
Pediatric Disease Annotations & Medicines
| Disease | multiple sclerosis |
| Phenotype | C0023524|progressive multifocal leucoencephalopathy |
| Sentences | 1 |
| PubMedID- 20547618 | Background and aim: natalizumab, used as therapy for multiple sclerosis (ms), has been associated with progressive multifocal leucoencephalopathy (pml), a potentially fatal disease caused by jc virus (jcv), which is not predictable by specific markers. |
Page: 1